Literature DB >> 19231335

Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy.

Nina Ajmone Marsan1, Gabe B Bleeker, Rutger J van Bommel, Claudia Ypenburg, Victoria Delgado, C Jan Willem Borleffs, Eduard R Holman, Ernst E van der Wall, Martin J Schalij, Jeroen J Bax.   

Abstract

The time course of the effects of cardiac resynchronization therapy (CRT) on left ventricular (LV) systolic function and reverse remodeling is still unknown and was the subject of this study. In particular, whether the acute benefit of CRT translates in late response was explored. Furthermore, the time course of response was compared between ischemic and nonischemic patients. A total of 222 consecutive patients with heart failure (135 ischemic) scheduled for CRT were included. Standard echocardiography was performed before, immediately after CRT, and at 6-month follow-up to measure LV end-systolic volume (ESV), LV end-diastolic volume (EDV), and ejection fraction. Immediately after CRT, significant improvements in LV ejection fraction (from 25 +/- 8% to 31 +/- 9%, p <0.001) and LVESV (from 163 +/- 68 to 149 +/- 63 ml, p <0.001) were observed, followed by an additional improvement at 6-month follow-up (to 34 +/- 9% and 132 +/- 62 ml, respectively, p <0.001 for the 2 comparisons). A significant decrease in LVEDV was observed only at 6-month follow-up (from 217 +/- 73 to 194 +/- 72 ml, p <0.001). An acute decrease in LVESV of 6% could predict response to CRT at 6-month follow-up (defined as a decrease >or=15% in LVESV) with a sensitivity and specificity of 79% and 75%, respectively. The time course of response to CRT was similar in ischemic and nonischemic patients, but decreases in LVESV and LVEDV were significantly greater in nonischemic patients (p <0.001). In conclusion, the beneficial effect of CRT on LV systolic function occurs immediately after CRT, with additional improvement at 6-month follow-up. An acute decrease in LVESV can predict response to CRT at 6-month follow-up. Nonischemic patients show significantly greater LV reverse remodeling compared with ischemic patients.

Entities:  

Mesh:

Year:  2008        PMID: 19231335     DOI: 10.1016/j.amjcard.2008.11.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Yuichiro Iida; Miwa Iwamoto-Ishida; Takeru Nabeta; Shunsuke Ishii; Takanori Sato; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Mototsugu Nishii; Junya Ako
Journal:  Heart Vessels       Date:  2015-02-17       Impact factor: 2.037

3.  Response to cardiac resynchronization therapy in non-ischemic cardiomyopathy is unrelated to medical therapy.

Authors:  Gregory Sinner; Hesham R Omar; You W Lin; Samy C Elayi; Maya E Guglin
Journal:  Clin Cardiol       Date:  2018-12-15       Impact factor: 2.882

Review 4.  Sex-related differences in patients' responses to heart failure therapy.

Authors:  Alon Barsheshet; Andrew Brenyo; Ilan Goldenberg; Arthur J Moss
Journal:  Nat Rev Cardiol       Date:  2012-02-14       Impact factor: 32.419

Review 5.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

6.  Characteristics of responders to cardiac resynchronization therapy: the impact of echocardiographic left ventricular volume.

Authors:  Mi Young Park; Robert K Altman; Mary Orencole; Prabhat Kumar; Kimberly A Parks; Kevin E Heist; Jagmeet P Singh; Michael H Picard
Journal:  Clin Cardiol       Date:  2012-08-09       Impact factor: 2.882

7.  Dyssynchrony Assessment with Tissue Doppler Imaging and Regional Volumetric Analysis by 3D Echocardiography Do Not Predict Long-Term Response to Cardiac Resynchronization Therapy.

Authors:  Suman S Kuppahally; Michael B Fowler; Randall Vagelos; Paul Wang; Amin Al-Ahmad; Henry Hsia; David Liang
Journal:  Cardiol Res Pract       Date:  2010-12-22       Impact factor: 1.866

8.  Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing.

Authors:  Maria-Aurora Morales; Umberto Startari; Giuseppe Rossi; Luca Panchetti; Andrea Rossi; Marcello Piacenti
Journal:  Cardiovasc Ultrasound       Date:  2011-12-16       Impact factor: 2.062

9.  Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy.

Authors:  Qi Wang; Kang-Yu Chen; Fei Yu; Hao Su; Chun-Sheng An; Yang Hu; Dong-Mei Yang; Jian Xu; Ji Yan
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

10.  Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.

Authors:  Yanmei Chen; Chongyang Duan; Feng Liu; Shuxin Shen; Pingyan Chen; Jianping Bin
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.